<DOC>
	<DOCNO>NCT02135835</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Shenfu Zhusheye patient acute heart failure .</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety Shenfu Zhusheye Patients With Acute Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Clinical diagnosis Acute Heart Failure accord Guidelines diagnosis treatment acute heart failure 2010 Chinese Medical Association ( Participants whose Heart function grade NYHA Ⅲ～Ⅳ ) . LVEF≤40 % . NTproBNP ≥1400 pg/mL BNP ≥ 350pg/mL . Ages 1880 , male female . All participant sign informed consent . Participants abnormal liver function ( ALT , AST≥3 time upper limit normal ) abnormal kidney function ( Cr≥1.5 time upper limit normal Cr &gt; 3.0 mg/dl ( &gt; 265 µmol/L ) ) . SBP ≥ 150mmHg . Participants severe chronic asthmatic bronchitis acute episode lung disease . Participants acute coronary syndrome , cardiogenic shock , aortic dissection , pulmonary embolism , severe ventricular arrhythmia , complete atrioventricular block without cardiac pacemaker , hypertrophic obstructive cardiomyopathy , restrictive cardiomyopathy severe valvular disease without surgery . Participants advance cancer . Breastfeeding , pregnant potentially fertile woman participant . Participants insanity . Known allergy Shenfu Zhusheye ingredient past . Participants take part clinical trial last month . Participants abuse alcohol drug last year . Participants suitable clinical trial doctor ' consideration .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>